Does smoking exposure affect response to treatment in children with primary monosymptomatic nocturnal enuresis?

Aksoy, Gülşah Kaya; Koyun, Nevin Semerci; Doğan, Çağla Serpil

doi:10.1016/j.jpurol.2019.10.012

Cited by 3 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies on adult female patients with secondary enuresis nocturna reported that smoking negatively affects bladder function and that smoking was identified as a risk factor for enuresis nocturna (21). A recent study on children with MEN demonstrated that the response to desmopressin treatment was lower in those exposed to cigarette smoke (22). Although there is scientific evidence on the relationship between MEN and exposure to cigarette smoke, no difference was found between the enuresis and control groups in terms of passive smoking in the present study.…”

Section: Discussioncontrasting

confidence: 85%

How effective is the duration of breastfeeding on monosymptomatic enuresis nocturna?

Gümüş¹,

Kargı²,

Öncel³

2022

New J Urol.

View full text Add to dashboard Cite

Objective: This study aimed to evaluate the relationship and duration of breastfeeding in monosymptomatic enuresis nocturna. Material and Methods: 150 children, 78 of whom were diagnosed with enuresis nocturna and 72 of whom were in the control group, who applied to our urology clinic between July 2020 and September 2020, were included in the study. The duration of breastfeeding, the number of children at home, formula feeding, parent education, and passive smoking were asked. Results: The mean age of 150 patients included in the study was 7.6 (5-10 years). The enuresis group consisted of 36 girls and 42 boys, while the control group consisted of 36 girls and 36 boys. In comparison, the number of household members was 7(3-10) in the enuresis group, 5(4-8) in the control group. There was a significant difference between both groups (p=0.008). When the duration of breastfeeding was evaluated, the significant difference between the enuresis group and the control group was found to be 18 months (p=0.016). There was no difference between the formula and feeding enuresis group and the control group (p=0.599). There was no difference between the two groups in terms of passive smoking and parental education. Conclusion: One of the most common disorders in childhood is enuresis nocturna. Continuing with age has many negative effects on the child. Our study observed that the incidence of enuresis decreased if breastfeeding was continued for more than 18 months. Readily available breastfeeding positively affects enuresis nocturna, similar to its effect on many aspects of childhood development. Keywords: Enuresis nocturna, breastfeeding, nutrition.

show abstract

Section: Discussioncontrasting

confidence: 85%

How effective is the duration of breastfeeding on monosymptomatic enuresis nocturna?

Gümüş¹,

Kargı²,

Öncel³

2022

New J Urol.

View full text Add to dashboard Cite

show abstract

“…In other words, it is necessary to confirm whether DDAVP is taken orally just before bedtime, and whether it is taken orally without water, because DDAVP that is prescribed in Japan is in the of OD tablets. Constipation and passive smoking have been reported to decrease the effectiveness of DDAVP treatment, 27,28 so, if necessary, treat constipation and remind guardians to cease smoking. Inspired by a previous report that excessive urinary sodium excretion decreases DDAVP treatment responsiveness in children with nocturnal enuresis, 29 we studied the effect of daily salt intake on DDAVP treatment responsiveness in children with nocturnal enuresis.…”

Section: How To M a Nage Pat I E N T S W I T H De Smopr E S Si N T R ...mentioning

confidence: 99%

Management of treatment‐resistant nocturnal enuresis

Tsuji

Kaneko

2023

Pediatrics International

View full text Add to dashboard Cite

Nocturnal enuresis is defined as intermittent urinary incontinence during sleep in children 5 years of age and older, occurring at least once a month for at least 3 months. In Japan, pediatricians who do not specialize in nocturnal enuresis have become more proactive in treating the condition since 2016, when the guidelines for treating it were revised for the first time in 12 years. For monosymptomatic nocturnal enuresis, the first step is lifestyle guidance, with a focus on the restriction of fluid intake at night; however, if lifestyle guidance does not decrease the frequency of nocturnal enuresis, aggressive treatment should be added. The first choice of aggressive treatment is oral desmopressin, an antidiuretic hormone preparation, or alarm therapy. However, there remain patients whose wet nights do not decrease with oral desmopressin or alarm therapy. In such cases, it is necessary to reconfirm the method of desmopressin administration and check for factors that may decrease the efficacy of desmopressin. If alarm therapy does not increase the number of dry nights, it is possible that the patient is fundamentally unsuitable for alarm therapy. If dry nights do not increase with oral desmopressin or alarm therapy, the next treatment strategy should be considered immediately to keep the patient motivated for treatment.

show abstract

The effect of screen time on the presentation and treatment of primary monosymptomatic nocturnal enuresis

Demirbaş

Gercek

2023

BMC Urol

View full text Add to dashboard Cite

Background We aimed to investigate if there was any relationship between screen time (ST) and the severity of primary monosymptomatic nocturnal enuresis (PMNE) and treatment success. Methods This study was conducted in urology and child and adolescent phsychiatry clinic in Afyonkarahisar Health Sciences University Hospital. After diagnosis patients were seperated by the ST for exploring causation. Group 1 > 120, Group 2 < 120 (min/day). For the the treatment response, patients were grouped again. Group 3 patients were administered 120 mcg Desmopressin Melt (DeM) and were requested < 60 min ST. Patients in Group 4 were given 120 mcg DeM solely. Results The first stage of the study included 71 patients. The ages of the patients ranged from 6 to 13. Group 1 comprised 47 patients, 26 males and 21 females. Group 2 comprised 24 patients,11 males and 13 famales. Median age was 7 years in both groups. The groups were similar in respect of age and gender (p = 0.670, p = 0.449, respectively). A significant relationship was determined between ST and PMNE severity. Severe symptoms were seen at the rate of 42.6% in the Group 1, and at 16.7% in the Group 2 (p = 0.033). 44 patients completed the second stage of the study. Group 3 comprised 21 patients, 11 males and 10 females. Group 4 comprised 23 patients,11 males and 12 famales. Median age was 7 years in both groups. The groups were similar in respect of age and gender (p = 0.708, p = 0.765, respectively). Response to treatment was determined as full response in 70% (14/20) in Group 3 and in 31% (5/16) in Group 4 (p = 0.021). Failure was determined in 5% (1/21) in Group 3 and in 30% (7/23) in Group 4 (p = 0.048). Recurrence was determined at a lower rate in Group 3 where ST was restricted (7% vs. 60%, p = 0.037). Conclusion High screen exposure may be a factor for PMNE aetiology. And also reducing ST to a normal range can be an easy and beneficial method for treatment of PMNE. Trial Registration ISRCTN15760867(www.isrctn.com). Date of registration: 23/05/2022. This trial was registered retrospectively.

show abstract

Does smoking exposure affect response to treatment in children with primary monosymptomatic nocturnal enuresis?

Cited by 3 publications

References 24 publications

How effective is the duration of breastfeeding on monosymptomatic enuresis nocturna?

How effective is the duration of breastfeeding on monosymptomatic enuresis nocturna?

Management of treatment‐resistant nocturnal enuresis

The effect of screen time on the presentation and treatment of primary monosymptomatic nocturnal enuresis

Contact Info

Product

Resources

About